Fundraising Fox

Bone Biologics

NASDAQ: BBLG

Boston, US · Delaware corporation

Biotech

Founders & leadership

JF
Jeff FrelickExecutive
DW
Deina WalshExecutive
SL
Steve La NeveExecutive
CS
Chia SooNamed on SEC filing
BW
Benjamin WuNamed on SEC filing

Board

BS
Bruce StroeverBoard director
JD
Jimmy DelshadBoard director
WC
William CoffinBoard director
JB
John BoothBoard director

Reported raises · per SEC filings

Form D private placements

$8.5M disclosed across 3 of 4 rounds · 2016–2023

▶$729KraisedNov 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Don R. HankeyDirector
  • Deina H. WalshExecutive Officer
  • Siddhesh AngleDirector
  • Bruce StroeverDirector
  • Erick LuceraDirector
  • Jeffrey FrelickExecutive Officer
Offering amount
$729K
Amount sold
$729K
Sales commissions
$51K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.9MraisedJul 2018 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Deina WalshExecutive Officer
  • Stephen R LaNeveExecutive Officer, Director
  • Don HankeyDirector
  • Bret HankeyDirector
  • Jimmy DelshadDirector
  • Bruce StroeverDirector
  • John BoothDirector
  • Jeff FrelickExecutive Officer
Offering amount
$5.9M
Amount sold
$5.9M
First sale
Jul 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedMar 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen R LaNeveExecutive Officer, Director
  • DEINA WALSHExecutive Officer
  • BRET HANKEYDirector
  • JEFFREY FRELICKExecutive Officer
  • JIMMY DELSHADDirector
  • BRUCE STROEVERDirector
  • JOHN BOOTHDirector
Offering amount
$10M
Amount sold
$1.9M
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MofferedMar 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chia SooDirector
  • Benjamin WuDirector
  • Jimmy DelshadDirector
  • William CoffinDirector
  • Bruce StroeverDirector
  • Jeff FrelickExecutive Officer
  • Deina WalshExecutive Officer
  • Steve La NeveExecutive Officer
  • John BoothDirector
Offering amount
$4.5M
First sale
Feb 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Bone Biologics completes ~$3M financing, runway to Q2 2027 | BBLG Stock Newsstocktitan.net · Jul 2026Bone Biologics Announces $3 Million Private Placement Financing with Potential Additional $6 Million from Warrants | Quiver Quantitativequiverquant.com · Jul 2026Bone Biologics raises $3M now, with up to $6M more from warrantsstocktitan.net · Jul 2026Investors – Bone Biologicsbonebiologics.com · Mar 2024Bone Biologics Completes $5.75 Million Round Of Financingprnewswire.com · Feb 2016

Frequently asked questions

How much funding has Bone Biologics raised?
Bone Biologics has disclosed $8.5M raised across 3 of its 4 known rounds.
Where is Bone Biologics headquartered?
Bone Biologics is headquartered in Boston, US.